MitoSciences, University of Oregon, Rosetta, University of California-Irvine, NSF, Loma Linda University, Larta Institute, Znomics, Oregon Health and Science University, Buck Institute for Age Research, Q Therapeutics, City of Hope, Helicos BioSciences, B | GenomeWeb

MitoSciences Licenses Ab Tech from U of Oregon for Toxicity Screening
MitoSciences has agreed to an exclusive license for monoclonal antibodies from the University of Oregon for use in its cell-based drug toxicity screening tests and multiplexing assays, the Eugene, Ore.-based company said this week.
The University will receive royalties from patent-related sales and $4.6 million in fixed quarterly cash payments over 10 years.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.